CAS 942123-43-5

Formule : C25H34N7O13PS

InChI : InChI=1S/C25H34N7O13PS/c1-12(2)42-25(37)40-11-47-46(38,45-19-14(7-33)44-23(20(19)39-3)31-5-4-16(35)30-24(31)36)41-8-15-13(34)6-17(43-15)32-10-29-18-21(26)27-9-28-22(18)32/h4-5,9-10,12-15,17,19-20,23,33-34H,6-8,11H2,1-3H3,(H2,26,27,28)(H,30,35,36)/t13-,14+,15+,17+,19+,20+,23+,46?/m0/s1

Code InChI : CJCYTUJOSMYXLE-JDLSZIHUSA-N

SMILES : CC(C)OC(=O)OCSP(=O)(OC[C@@H]1[C@H](C[C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O[C@@H]4[C@H](O[C@H]([C@@H]4OC)N5C=CC(=O)NC5=O)CO

Inarigivir soproxil

CAS : 942123-43-5

Inarigivir soproxil

Formule : C₂₅H₃₄N₇O₁₃PS

Degré de pureté : ≥98%

Masse moléculaire : 703.62

Ref: 54-BUP04257

Inarigivir soproxil

CAS : 942123-43-5

Inarigivir soproxil (SB9200) boosts innate immunity, combats HCV 1a/1b (EC50: 2.2/1.0 μM).

Formule : C₂₅H₃₄N₇O₁₃PS

Degré de pureté : 98.35%

Couleur et forme : White Solid

Masse moléculaire : 703.62

Ref: TM-T15573

(((((2R,3S,5R)-5-(6-Amino-9H-purin-9-yl)-3-hydroxytetrahydrofuran-2-yl)methoxy)(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-(hydroxymethyl)-4-methoxytetrahydrofuran-3-yl)oxy)phosphoryl)thio)methyl isopropyl carbonate

CAS : 942123-43-5

Formule : C₂₅H₃₄N₇O₁₃PS

Degré de pureté : %

Masse moléculaire : 703.6153

Ref: IN-DA01EOSX

Inarigivir soproxil

CAS : 942123-43-5

(((((2R,3S,5R)-5-(6-Amino-9H-purin-9-yl)-3-hydroxytetrahydrofuran-2-yl)methoxy)(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-(hydroxymethyl)-4-methoxytetrahydrofuran-3-yl)oxy)phosphoryl)thio)methyl isopropyl carbonate

Formule : C₂₅H₃₄N₇O₁₃PS

Degré de pureté : 98+%

Masse moléculaire : 703.62

Ref: IN-DG764496

Inarigivir Soproxil

CAS : 942123-43-5

Inarigivir Soproxil is a viral replication inhibitor that targets the nucleocapsid protein of the virus. The drug inhibits viral replication by binding to the RNA strand, which blocks the synthesis of viral proteins and thus prevents the virus from reproducing. This drug binds to the viral RNA strand, preventing it from being translated into proteins. Inarigivir Soproxil has been shown to be effective against hepatitis A, B, and C viruses as well as HIV-1 strains that do not have a protease mutation. It has also shown efficacy in treating hepatitis C virus (HCV) infection in patients who are co-infected with HIV-1.

Formule : C₂₅H₃₄N₇O₁₃PS

Degré de pureté : Min. 95%

Masse moléculaire : 703.62 g/mol

Ref: 3D-SMB12343

Inarigivir Soproxil

Produit contrôlé

CAS : 942123-43-5

Formule : C₂₅H₃₄N₇O₁₃PS

Couleur et forme : Neat

Masse moléculaire : 703.615

Ref: TR-I627015